Graybug Vision   Report issue

For profit Phase 2
Founded: Redwood City CA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2017
NCT03249740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Graybug Vision | Graybug Vision, Inc.